Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2026-04-09 @ 3:01 PM
Study NCT ID:
NCT00914303
Status:
COMPLETED
Last Update Posted:
2010-04-06
First Post:
2009-06-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate Different Extended Release (ER)-Formulations and Multiple Ascending Dosing of AZD3241
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D0490C00002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Rolf Karlsten , MD, PhD, Medical Science Director
Old Organization:
AstraZeneca Pharmaceuticals